Nadjoua Maouche

Statistics

Publications

Citations

H-Index

Active since

2019

Affiliations

Oxford University Hospitals NHS Trust(Current)

Nadjoua Maouche is an author at Oxford University Hospitals NHS Trust specializing in clinical pharmacology, stem cell transplantation, and chemotherapy.

ORCID

Publications per year

2019–2024

Publications

Real-world effectiveness and safety of ixazomib-lenalidomide-dexamethasone in relapsed/refractory multiple myeloma

Evangelos Terpos, Karthik Ramasamy, Nadjoua Maouche et al. · Annals of Hematology · 2020 · 41 citations

Medicine, Hematology, Pharmacotherapy +13

Treatment stratification of respiratory syncytial virus infection in allogeneic stem cell transplantation

Katalin Balassa, Richard Anthony Salisbury, Edmund Watson et al. · Journal of Infection · 2019 · 13 citations

Life Sciences, Immunology, Infectious Diseases +16

Tranexamic acid versus placebo to prevent bleeding in patients with haematological malignancies and severe thrombocytopenia (TREATT): a randomised, double-blind, parallel, phase 3 superiority trial

Lise J Estcourt, Zoe McQuilten, Peter Bardy et al. · The Lancet Haematology · 2024 · 13 citations · Full text

Medicine, Hematology, Pharmacology +13

1–3 of 3